Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-22T23:45:55.752Z Has data issue: false hasContentIssue false
  • English
  • Français

No antibody binding to serotonin in serum of patients with paranoid schizophrenia and major depressive disorder

Published online by Cambridge University Press:  16 April 2020

K Schott  and
A Batra
K Schott
Affiliation:
Psychiatrische Universitätsklinik, Osianderstrasse 22, 72076, Tübingen, Germany
A Batra
Affiliation:
Psychiatrische Universitätsklinik, Osianderstrasse 22, 72076, Tübingen, Germany

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

antibodydepressionschizophreniaserotonin
Type
Letter to the editor
Information
European Psychiatry , Volume 10 , Issue 7 , 1995 , pp. 372
Copyright
Copyright © Elsevier, Paris 1995

References

Schott, KBatra, AKlein, RBartels, MKoch, WBerg, PAAntibodies against serotonin and gangliosides in schizophrenia and major depressive disorder. Eur Psychiatry 1992; 7: 209–12CrossRefGoogle Scholar
Spitzer, RLEndicott, JRobins, E.Research diagnostic criteria Arch Gen Psychiatry 1978; 35: 773–82CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.